Poet Faces Legal Risk and Tax Questions but There is Upside Potential

I’ll cut to the chase. POET Technologies (NASDAQ:POET) just lived through one of the more brutal weeks in small-cap semiconductors, and the wreckage has reset the setup.

Our 24/7 Wall St. price target for POET is $10.51 over the next 12 months, implying 59.28% upside from $6.60. Confidence sits at moderate, roughly 50%, reflecting genuine asymmetry against very real legal and dilution risk.

24/7 Wall St. Price Target Summary

The Lawsuit That Cracked the Rally

POET fell 17.81% on April 29 and 48.32% over the past week, yet remains up 62.16% over the past year and 29.92% over the past month.

The trigger was a Rosen Law Firm class action filed April 29 covering buyers between April 1 and April 27, 2026, alleging misleading statements about POET’s Passive Foreign Investment Company status. That followed an April 14 Wolfpack Research short report calling the story a stock promote with a tax problem.

Management has responded by committing to QEF election documentation and a redomicile to the United States, with a shareholder vote on June 26, 2026. Q4 2025 showed revenue of $341,202 and EPS of -$0.32, missing expectations, but POET ended the period with $430 million in cash.

Why Bulls See a Breakout to $17

The bull case rests on optical engine commercialization. POET secured a production order exceeding $5 million for optical engines and is targeting shipments of more than 30,000 optical engines in 2026. Strategic partnerships with LITEON Technology on next-gen AI data center modules and Lessengers on 1.6T 2xDR4 optical transceivers point at a real product roadmap into co-packaged optics for hyperscalers.

If those ramps land, our bull scenario points to $17.05, a 158.33% return. Simply Wall Street published a $17.37 fair value estimate, and the 52-week high of $15.50 shows the market has paid up before.

The Risks Worth Watching

The bear case is concrete. The Rosen class action overhangs the stock, and Wolfpack flagged a seventh business pivot, repeated dilution, and rich valuation at a price-to-sales ratio of 1140 on trailing revenue of $1,074,900.

Bulls would counter that POET is mid-pivot from R&D to volume manufacturing, that quarterly revenue growth was 10.75%, and that the $525 million raised since 2025 funds the optical engine ramp without near-term going-concern risk. Still, our bear scenario lands at $8.40, with the 52-week low of $3.87 as the worst-case anchor if the lawsuit drags into 2027.

I’d Buy the Dislocation, Carefully

My 24/7 Wall St. price target stays at $10.51 with a buy rating and moderate confidence. The single factor that tips the scale is cash. POET has the runway to ship product before the legal cycle resolves.

I’d be a buyer here if the June 26 redomicile vote passes and Q2 shipments confirm the 30,000-unit pace. I’d stay on the sidelines if dilution accelerates or the lawsuit expands beyond PFIC disclosures.

Looking further ahead, here is where our 24/7 Wall St. price target model projects POET could trade, assuming optical engine volumes scale and the U.S. redomicile resolves the PFIC overhang.

These projections track our base-case 5-year output of $23.54 by April 2031. Significant upside or downside could result from hyperscaler design wins or an adverse lawsuit settlement.